BioSpace News Archive

Athersys, Inc., a regenerative medicine company developing MultiStem® for critical care indications, announced it will host a business update conference call on October 6, 2022 at 4:00 pm Eastern Time.

AB Science SA reports its revenues for the first half of 2022 and provides an update on its activities.

AIkido Pharma Inc. (NASDAQ: AIKI) (“AIkido” or the “Company”) today provided an update on the $3 million share repurchase program (the “Share Repurchase Program”) authorized by the Company’s Board of Directors on January 21, 2022.

Applied DNA Sciences, Inc. today announced the publication of a manuscript, co-authored with international academic and industry scientists, containing data demonstrating that a LinearDNA™-based vaccine candidate (the “vaccine candidate”) reduced infectious virus shedding and was protective against SARS-CoV-2 in a challenge trial in ferrets.

Cloud DX (TSXV:CDX) (OTC:CDXFF), a leading Canadian digital health platform and provider of virtual and remote care solutions announces the company’s attendance by invitation at Opportunity Collaborative (OC) Impact 2022 in Michès, Dominican Republic.

The National Association of Chronic Disease Directors (NACDD) is pleased to introduce two new officers and seven incoming Board Members for its Fiscal Year 2022-2023.

Seelos Therapeutics, Inc. today announced it will collaborate with the Sean M. Healey & AMG Center for ALS in an Expanded Access Program (EAP) that will be fully funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the ACT for ALS.

NeoSpectra by Si-Ware today announced the release of the first-of-its-kind marketplace of near-infrared (NIR) calibration models with the launch of the NeoSpectra LabStore.

Cytokinetics, Incorporated presented new data on the reduction and withdrawal of background standard of care medical therapy in patients treated with aficamten in REDWOOD-HCM OLE in a Late Breaking Clinical Trials session at the 2022 HCM Society Scientific Sessions, the inaugural scientific sessions of this newly launched professional medical society, held in National Harbor, MD.

Mentice AB a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company’s Annual General Meeting 2023 has been appointed.